Dr. Bennett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8008 Frost St
Ste 200
San Diego, CA 92123Phone+1 858-292-7527Fax+1 858-292-7804
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 1981 - 1983
Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 1977 - 1980
Georgetown University School of MedicineClass of 1977
Certifications & Licensure
CA State Medical License 1978 - 2026
OR State Medical License 1980 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Publications & Presentations
PubMed
- 492 citationsAll-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III StudyDavid R. Nelson, James N. Cooper, Jacob Lalezari, Eric Lawitz, Paul J. Pockros
Hepatology. 2015-04-01 - 222 citationsGS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver DiseaseRohit Loomba, Zeid Kayali, Mazen Noureddin, Peter Ruane, Eric Lawitz
Gastroenterology. 2018-11-01 - 22 citationsSafety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff
Journal of Hepatology. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
